🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Si‐Yang Li

Si‐Yang Li

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis”.

Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.10.292508

N/A

0DataRank · unranked

1 citations

Si‐Yang Li, Thomas R. Ioerger, Keshav V. Shah, Jean‐Philippe Lanoix, Jin Lee +4 more

Differential in vitro activity of individual drugs and bedaquiline-rifabutin combinations against actively multiplying and nutrient-starved Mycobacterium abscessus

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.14.340422

N/A

0DataRank · unranked

0 citations

Nicole C. Ammerman, Anusha Agarwal, Maram Naji, Si‐Yang Li, Eric L. Nuermberger +1 more

Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

Nature Communications(2022)10.1038/s41467-022-33736-5

N/A

0DataRank · unranked

34 citations

Susan H. Davis, Sebastian Damerow, Curtis A. Engelhart, Michael Mathieson, Beatriz Baragaña +40 more

GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.04.479214

N/A

0DataRank · unranked

11 citations

Maria Santos Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Heena Soni +25 more

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00481-23

N/A

0DataRank · unranked

2 citations

Si‐Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steve P. Rannard +4 more

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.12.536604

N/A

0DataRank · unranked

0 citations

Si‐Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steve P. Rannard +4 more

Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.03.583160

N/A

0DataRank · unranked

2 citations

Amit Kaushik, Paul Curley, Usman Arshad, Eman El‐Khateeb, Si‐Yang Li +11 more